格隆汇3月4日丨雍禾医疗(02279.HK)发布公告,截至2024年12月31日止年度(“该年度”),集团于该年度的净亏损将大幅减少至不多于人民币2.462亿元。与截至2023年12月31日止年度的净亏损约为人民币5.467亿元相比,预期集团于该年度的净亏损减幅录得不低于约55.0%。根据目前可得资料,董事会认为上述预期净亏损大幅减少主要归因于(其中包括)以下原因:(i)运营效率提升带来的毛利润及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.